Page last updated: 2024-10-28

beta-thujaplicin and Cancer of Endometrium

beta-thujaplicin has been researched along with Cancer of Endometrium in 1 studies

beta-thujaplicin: structure
beta-thujaplicin : A monoterpenoid that is cyclohepta-2,4,6-trien-1-one substituted by a hydroxy group at position 2 and an isopropyl group at position 4. Isolated from Thuja plicata and Chamaecyparis obtusa, it exhibits antimicrobial activities.

Research Excerpts

ExcerptRelevanceReference
"To date, the effects of hinokitiol on endometrial cancer (EC) has not been explored."1.62Hinokitiol Exhibits Antitumor Properties through Induction of ROS-Mediated Apoptosis and p53-Driven Cell-Cycle Arrest in Endometrial Cancer Cell Lines (Ishikawa, HEC-1A, KLE). ( Ali, M; Chang, HY; Chen, HY; Cheng, WP; Chiang, YF; Hong, YH; Hsia, SM; Huang, TC; Shieh, TM; Wang, KL, 2021)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Chen, HY1
Cheng, WP1
Chiang, YF1
Hong, YH1
Ali, M1
Huang, TC1
Wang, KL1
Shieh, TM1
Chang, HY1
Hsia, SM1

Other Studies

1 other study available for beta-thujaplicin and Cancer of Endometrium

ArticleYear
Hinokitiol Exhibits Antitumor Properties through Induction of ROS-Mediated Apoptosis and p53-Driven Cell-Cycle Arrest in Endometrial Cancer Cell Lines (Ishikawa, HEC-1A, KLE).
    International journal of molecular sciences, 2021, Jul-31, Volume: 22, Issue:15

    Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Autophagy; Cell Cycle Checkpoints; Cell Line, Tumor; C

2021